Advertisement

Geron Corporation GERN

Set alert

Price alert · GERN

All alert types
0.89 USD -0.05 -5.47%

At close · Oct 30

0.89 0.00 -0.48%

After hours · Oct 30, 7:38 PM ET

Bid
0.89 × 1
Ask
0.89 × 1
0.8606 Day range 0.9373
0.8944 52-week range 1.95
YTD
-32.24%
1 year
-27.87%
Open
0.93
Prev close
0.9462
Mkt cap
574.63M
Vol
18.81M
Avg vol
11.48M
EPS
-0.11
P/E
0.00
Div yield
0.00%
More statistics
Low
0.8606
High
0.9373
Forward P/E
39.25
Beta
0.60
Short ratio
7.70
Inst. own
76.50%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
1.47
200-d avg
1.44
1y target
4.25

MAX chart

Chart tools
Interval

Events in this range
  • Aug 6, 2025Earnings: -0.02; estimate -0.03; surprise 33.33%
  • Nov 5, 2025Earnings: -0.03; estimate -0.03667; surprise 18.19%
  • Nov 5, 2025Rating: Needham · Buy → Buy
  • May 6, 2026Earnings: -0.01; estimate -0.03; surprise 66.67%
  • Aug 5, 2026Earnings: -0.02; estimate -0.00888; surprise -125.23%
  • Nov 4, 2026Earnings: —; estimate -0.01; surprise —%
Signals (161)
NameDateAgo
MACD: Sell SignalOct 30, 20261 day ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 1, 20263 months ago
MACD: Buy SignalAug 1, 20263 months ago
SMA: BearishMay 1, 20266 months ago
SMA: BullishJan 1, 202610 months ago
SMA: BearishJan 1, 20251 year ago
MACD: Sell SignalJan 1, 20251 year ago
SMA: BearishDec 1, 20241 year ago
MACD: Buy SignalApr 1, 20242 years ago
SMA: BullishMar 1, 20242 years ago
SMA: BullishMar 1, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BearishOct 1, 20233 years ago
MACD: Sell SignalSep 1, 20233 years ago
SMA: BearishAug 1, 20233 years ago
SMA: BullishApr 1, 20233 years ago
SMA: BearishMar 1, 20233 years ago
RSI: OverboughtJan 1, 20233 years ago
SMA: BullishJun 1, 20224 years ago
MACD: Buy SignalApr 1, 20224 years ago
SMA: BullishMar 1, 20224 years ago
SMA: BearishDec 1, 20214 years ago
MACD: Sell SignalDec 1, 20214 years ago
SMA: BearishNov 1, 20215 years ago
SMA: BullishOct 1, 20215 years ago
SMA: BullishOct 1, 20215 years ago
MACD: Buy SignalOct 1, 20215 years ago
MACD: Sell SignalJul 1, 20215 years ago
SMA: BearishApr 1, 20215 years ago
SMA: BullishJan 1, 20215 years ago
SMA: BullishJan 1, 20215 years ago
SMA: BearishDec 1, 20205 years ago
SMA: BearishDec 1, 20205 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BearishSep 1, 20206 years ago
SMA: BullishAug 1, 20206 years ago
SMA: BearishJul 1, 20206 years ago
SMA: BullishJun 1, 20206 years ago
SMA: BullishMay 1, 20206 years ago
MACD: Buy SignalApr 1, 20206 years ago
MACD: Sell SignalOct 1, 20188 years ago
SMA: BearishSep 1, 20188 years ago
SMA: BearishSep 1, 20188 years ago
SMA: BullishMar 1, 20188 years ago
SMA: BullishMar 1, 20188 years ago
SMA: BearishFeb 1, 20188 years ago
MACD: Buy SignalFeb 1, 20188 years ago
SMA: BullishJan 1, 20188 years ago
MACD: Sell SignalNov 1, 20179 years ago
SMA: BearishAug 1, 20179 years ago
MACD: Buy SignalJun 1, 20179 years ago
SMA: BullishApr 1, 20179 years ago
MACD: Sell SignalFeb 1, 201610 years ago
SMA: BearishJan 1, 201610 years ago
SMA: BearishJan 1, 201610 years ago
SMA: BullishNov 1, 201511 years ago
MACD: Buy SignalNov 1, 201511 years ago
SMA: BullishOct 1, 201511 years ago
SMA: BearishSep 1, 201511 years ago
MACD: Sell SignalSep 1, 201511 years ago
SMA: BearishAug 1, 201511 years ago
SMA: BullishNov 1, 201412 years ago
MACD: Buy SignalNov 1, 201412 years ago
SMA: BullishOct 1, 201412 years ago
SMA: BearishSep 1, 201412 years ago
MACD: Sell SignalJul 1, 201412 years ago
SMA: BullishJun 1, 201412 years ago
SMA: BearishMar 1, 201412 years ago
SMA: BearishMar 1, 201412 years ago
RSI: OverboughtNov 1, 201313 years ago
SMA: BullishSep 1, 201313 years ago
SMA: BullishAug 1, 201313 years ago
SMA: BearishJul 1, 201313 years ago
SMA: BullishJun 1, 201313 years ago
SMA: BearishSep 1, 201214 years ago
SMA: BullishAug 1, 201214 years ago
MACD: Buy SignalAug 1, 201214 years ago
RSI: OversoldMay 1, 201214 years ago
RSI: OversoldNov 1, 201115 years ago
RSI: OversoldSep 1, 201115 years ago
SMA: BearishDec 1, 201015 years ago
SMA: BearishDec 1, 201015 years ago
MACD: Sell SignalDec 1, 201015 years ago
MACD: Buy SignalNov 1, 201016 years ago
SMA: BullishSep 1, 201016 years ago
SMA: BullishSep 1, 201016 years ago
SMA: BearishAug 1, 201016 years ago
SMA: BearishAug 1, 201016 years ago
SMA: BullishJul 1, 201016 years ago
SMA: BullishJul 1, 201016 years ago
SMA: BearishMay 1, 201016 years ago
MACD: Sell SignalMay 1, 201016 years ago
SMA: BullishFeb 1, 201016 years ago
SMA: BearishNov 1, 200917 years ago
SMA: BearishOct 1, 200917 years ago
SMA: BullishMay 1, 200917 years ago
SMA: BullishApr 1, 200917 years ago
SMA: BearishFeb 1, 200917 years ago
SMA: BearishFeb 1, 200917 years ago
SMA: BullishJan 1, 200917 years ago
MACD: Buy SignalJan 1, 200917 years ago
SMA: BullishDec 1, 200817 years ago
SMA: BearishNov 1, 200719 years ago
SMA: BullishOct 1, 200719 years ago
MACD: Sell SignalJul 1, 200719 years ago
SMA: BearishJun 1, 200719 years ago
SMA: BearishJun 1, 200719 years ago
SMA: BullishMay 1, 200719 years ago
SMA: BullishMay 1, 200719 years ago
MACD: Buy SignalMay 1, 200719 years ago
SMA: BearishMar 1, 200719 years ago
MACD: Sell SignalMar 1, 200719 years ago
SMA: BearishFeb 1, 200719 years ago
MACD: Buy SignalDec 1, 200619 years ago
SMA: BullishOct 1, 200620 years ago
SMA: BullishOct 1, 200620 years ago
MACD: Sell SignalApr 1, 200620 years ago
SMA: BearishMar 1, 200620 years ago
SMA: BullishFeb 1, 200620 years ago
SMA: BearishDec 1, 200520 years ago
SMA: BearishDec 1, 200520 years ago
SMA: BullishMay 1, 200521 years ago
SMA: BullishMay 1, 200521 years ago
MACD: Buy SignalMay 1, 200521 years ago
MACD: Sell SignalMar 1, 200521 years ago
SMA: BearishFeb 1, 200521 years ago
SMA: BearishFeb 1, 200521 years ago
MACD: Buy SignalJan 1, 200521 years ago
SMA: BullishDec 1, 200421 years ago
SMA: BullishOct 1, 200422 years ago
SMA: BearishJul 1, 200422 years ago
MACD: Sell SignalJul 1, 200422 years ago
SMA: BearishFeb 1, 200422 years ago
SMA: BullishJul 1, 200323 years ago
SMA: BullishMar 1, 200323 years ago
MACD: Buy SignalMar 1, 200323 years ago
SMA: BearishSep 1, 200125 years ago
SMA: BullishAug 1, 200125 years ago
SMA: BearishFeb 1, 200125 years ago
SMA: BullishJan 1, 200125 years ago
SMA: BearishNov 1, 200026 years ago
MACD: Sell SignalNov 1, 200026 years ago
SMA: BearishSep 1, 200026 years ago
SMA: BullishAug 1, 200026 years ago
SMA: BearishJul 1, 200026 years ago
SMA: BullishJun 1, 200026 years ago
SMA: BearishMay 1, 200026 years ago
RSI: OverboughtJan 1, 200026 years ago
SMA: BullishDec 1, 199926 years ago
MACD: Buy SignalDec 1, 199926 years ago
SMA: BullishNov 1, 199927 years ago
SMA: BearishOct 1, 199927 years ago
MACD: Sell SignalOct 1, 199927 years ago
SMA: BearishAug 1, 199927 years ago
SMA: BullishNov 1, 199828 years ago
SMA: BearishJun 1, 199828 years ago
SMA: BullishJan 1, 199828 years ago
SMA: BearishNov 1, 199729 years ago
SMA: BullishSep 1, 199729 years ago

Key statistics

Market cap
1.01B
Enterprise value
829.98M
Trailing P/E
0.00
Forward P/E
39.25
PEG ratio
0.00
Price / sales
4.93
Price / book
4.62
EPS (TTM)
-0.11
Beta
0.60
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-33.05%
Revenue (TTM)
204.56M
Revenue growth
17.20%
Free cash flow
-78.37M
Total cash
300.85M
Total debt
122.14M
Return on equity
-28.28%
Shares outstanding
642.47M
Short % of float
12.56%
50-day average
1.47
200-day average
1.44

Analyst view

Consensus: none

Price target (mean) 4.25 +375.2% upside
Target (low)
3.00
Target (mean)
4.25
Target (high)
6.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate -0.01.

Earnings history

Financials — quick view

All financials
GERN Revenue — quarterly 57.48M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GERN Net income — quarterly -16.68M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GERN EPS — quarterly -0.02
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

GERN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 2026-0.01———
Aug 5, 2026Jun 30, 2026-0.00888-0.02-0.01-125.23%
May 6, 2026Mar 31, 2026-0.03-0.01+0.02+66.67%
Feb 25, 2026Dec 31, 2025-0.03-0.030.000.00%
Nov 5, 2025Sep 30, 2025-0.03667-0.03+0.01+18.19%
Aug 6, 2025Jun 30, 2025-0.03-0.02+0.01+33.33%

Upgrades / downgrades

GERN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 5, 2025NeedhammainBuyBuy
May 8, 2025ScotiabankdownSector OutperformSector Perform
Mar 12, 2025NeedhamreitBuyBuy
Mar 12, 2025HC Wainwright & Co.reitNeutralNeutral
Feb 27, 2025ScotiabankmainSector OutperformSector Outperform
Feb 27, 2025StifelmainBuyBuy

About Geron Corporation

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
geron.com

News

Your note

Sign in to keep a note on GERN — it syncs with the Stock Master app.

Insider holders

GERN insider holders
InsiderRelationLatest transactionDateShares held
LAWLIS VIRGIL BRYAN JR.DirectorPurchaseMay 8, 202513,300
ROBERTSON MICHELLEChief Financial OfficerConversion of Exercise of derivative securityFeb 17, 202617,645
SAMUELS SCOTT ALANOfficerPurchaseFeb 26, 202526,682
SCARLETT JOHN AChief Executive OfficerPurchaseFeb 26, 2025137,500
SPIEGEL ROBERT JDirectorStock Award(Grant)Jun 29, 2026205,810
ZIEGLER JAMESOfficerPurchaseFeb 26, 2025100,000

Institution ownership

GERN institution ownership
Holder% heldSharesValueReported
Blackrock Inc.7.64%49,115,57177.11MJun 29, 2026
Soleus Capital Management, L.P.6.66%42,808,65967.21MJun 29, 2026
RA Capital Management, L.P.6.66%42,809,75167.21MJun 29, 2026
State Street Corporation5.58%35,856,67156.29MJun 29, 2026
Citadel Advisors Llc4.52%29,038,92845.59MJun 29, 2026
Vanguard Capital Management LLC4.24%27,250,21542.78MJun 29, 2026

Fund ownership

GERN fund ownership
Holder% heldSharesValueReported
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF3.40%21,816,98734.25MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.18%20,449,23432.11MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.25%14,478,73022.73MJun 29, 2026
Vanguard Explorer Fund1.58%10,174,59215.97MApr 29, 2026
Legg Mason Partners Investment Trust-ClearBridge Small Cap Growth Fund0.98%6,316,1109.92MApr 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.95%6,108,3709.59MJun 29, 2026
Advertisement